CCL2 Antikörper
Kurzübersicht für CCL2 Antikörper (ABIN2725643)
Target
Alle CCL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Immunogen
- Purified recombinant protein of human MCP-1 (NP_002973) produced in HEK293T cell.
-
Isotyp
- IgG1
-
-
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) antibody
CCL2 Reaktivität: Human, Maus, Affe WB, IHC, ELISA, ICC, FACS Wirt: Maus Monoclonal 2D8 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 61-148) antibodyCCL2 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC (p), IF (p), IHC (fro), IF (cc) Wirt: Kaninchen Polyclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 62-89), (C-Term) antibodyCCL2 Reaktivität: Human WB, IHC (p), IF, FACS Wirt: Kaninchen Polyclonal RB17838 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) antibodyCCL2 Reaktivität: Human WB, IHC, ELISA, IHC (p), IF, FACS Wirt: Maus Monoclonal 2D8 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 24-96) antibodyCCL2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Maus Monoclonal C1 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 62-89) antibodyCCL2 Reaktivität: Human WB, IHC, ELISA, IF, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) antibodyCCL2 Reaktivität: Human, Maus, Affe WB, IHC (p), IF, FACS, EIA Wirt: Maus Monoclonal 2D8 unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 24-99) antibodyCCL2 Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) antibodyCCL2 Reaktivität: Maus WB, ELISA, Neut Wirt: Kaninchen Polyclonal unconjugated
anti-Chemokine (C-C Motif) Ligand 2 (CCL2) (AA 24-99) antibodyCCL2 Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- ELISA, LMNX 1:100 - 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
-
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
-
Andere Bezeichnung
- MCP-1
-
NCBI Accession
- NM_002982
-
HGNC
- 6347
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-
